Additionally, we observed a slight increase in portal GLP-1 levels with B. pseudolongum treatment, although it did not reach significance (Fig. 8c).This was accompanied by increases in NTS activation following a SI lipid infusion in 3-day B. pseudolongum-treated rats on a HF-diet (Fig. 8d-e). The gene discussed is GLP1R; the disease is hydrops fetalis.